Differential Regulation of SIRT5 Activity by Reduced Nicotinic Acid Riboside (NARH)

Area of Science:

• Biochemistry
• Enzymology
• Molecular Biology

Background:

• Sirtuin 5 (SIRT5) is a key human sirtuin enzyme involved in regulating metabolism, reducing reactive oxygen species (ROS), and detoxifying ammonia.
• SIRT5 exhibits broad deacylase activity, including desuccinylation, demalonylation, and deglutarylation, in addition to its deacetylase function.
• SIRT5 is implicated as a therapeutic target for neurodegenerative diseases, metabolic disorders, and cancer.

Purpose of the Study:

• To identify and characterize modulators of SIRT5 activity.
• To investigate the differential effects of a novel modulator on SIRT5's distinct enzymatic functions.
• To elucidate the binding mechanism and site of the identified SIRT5 modulator.

Main Methods:

• Biochemical assays to assess SIRT5 enzymatic activities (deacetylation, desuccinylation).
• Cellular assays to confirm target engagement and activity of the modulator.
• Computational approaches (e.g., molecular docking, simulations) to investigate the binding site.

Main Results:

• Identification and characterization of reduced nicotinic acid riboside (NARH) as a SIRT5 modulator.
• NARH demonstrates differential regulation: it activates SIRT5 desuccinylation while mildly suppressing deacetylation.
• NARH binds to SIRT5 independently of NAD+, shows cellular activity, and its binding site was investigated through biochemical and computational methods.

Conclusions:

• NARH provides a novel chemical scaffold for developing specific SIRT5 activators.
• This study enhances mechanistic understanding of SIRT5 regulation.
• The findings support the therapeutic potential of targeting SIRT5 in various disease contexts.